We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.34B
AUM Growth
-$657M
Cap. Flow
-$485M
Cap. Flow %
-11.17%
Top 10 Hldgs %
42.98%
Holding
79
New
16
Increased
24
Reduced
23
Closed
15

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$94.7M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$93M
3
BHC icon
Bausch Health
BHC
+$72.6M
4
CPAY icon
Corpay
CPAY
+$65.7M
5
VMC icon
Vulcan Materials
VMC
+$64.8M

Top Sells

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$185M
2
AGN
Allergan Inc
AGN
+$144M
3
MCK icon
McKesson
MCK
+$132M
4
BKNG icon
Booking.com
BKNG
+$130M
5
MDVN
MEDIVATION, INC.
MDVN
+$98.6M

Sector Composition

Rank Sector Weight
1 Healthcare 33.04%
2 Communication Services 18.99%
3 Materials 9.44%
4 Technology 8.93%
5 Energy 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEGR
76
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-335,921
Closed -$10.8M
RCPT
77
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
– –
-72,283
Closed -$3.08M
RPRX
78
DELISTED
Repros Therapeutics Inc.
RPRX
– –
-850,942
Closed -$14.7M
1 2 3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q3 2014 Portfolio in Review

As of Q3 2014, PFM Health Sciences held 79 positions worth $4.34B, down 13% from $5B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

PFM Health Sciences withdrew a net $485M in Q3 2014, closing 15 positions and reducing 23 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $185M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 38% a quarter earlier, followed by Communication Services and Materials.

Against the trend, PFM Health Sciences opened a new position in Corpay worth $67.8M.

  • PFM Health Sciences's largest Q3 2014 buy was Corpay: 477,040 shares worth $67.8M.
  • PFM Health Sciences added most to Baidu in Q3 2014, an estimated $94.7M increase.
  • PFM Health Sciences's biggest Q3 2014 reduction was Allergan Inc, cutting an estimated $144M.
  • PFM Health Sciences fully exited Walgreens Boots Alliance in Q3 2014, selling an estimated $185M.
  • PFM Health Sciences's ten largest holdings make up 43% of its $4.34B portfolio in Q3 2014.
  • PFM Health Sciences opened 16 new positions and closed 15 in Q3 2014.
  • PFM Health Sciences's portfolio value fell 13% quarter-over-quarter to $4.34B.

Based on PFM Health Sciences's 13F filing for Q3 2014, filed 14 Nov 2014.